Design, synthesis and antimicrobial activities evaluation for new sulphathiazole amide compounds
Chemical and Environmental Science Archives · 2024
DOI: 10.47587/cesa.2024.4201 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemical and Environmental Science Archives, 2024. Verfasst von Abdulnaser J. A. Almustafa und 2 weiteren Autor:innen.
Abstract (Originalsprache)
The ADME study was conducted to ensure their drug-likeness properties before testing their biological activities. The docking results represent 8 amide compounds were better than the standard antibacterial agents and after they were synthesized and their chemical structures were characterized, the ADME study represents acceptable drug likeness outcome. These compounds have no BBB penetration and acceptable GI crossing ability. These properties will give a good chance for the tested compounds to be available in the peripheral circulation and not to produce any unwanted central side effects, if they were accepted as drugs in the future during the clinical trials. Also, almost all the tested compounds signify inhibiting ability for the livers CYP450 enzymes, consequently, they are believed to be enzyme inhibitors if they were admitted as drugs. The sulfathiazole amides were within the Drug likeness and Lipinski rules.
Zitieren
APA
Almustafa, A. J. A., Kaya, K., & Mahmood, A. A. J. (2024). Design, synthesis and antimicrobial activities evaluation for new sulphathiazole amide compounds. Chemical and Environmental Science Archives. https://doi.org/10.47587/cesa.2024.4201
Vancouver
Almustafa AJA, Kaya K, Mahmood AAJ. Design, synthesis and antimicrobial activities evaluation for new sulphathiazole amide compounds. Chemical and Environmental Science Archives. 2024. doi:10.47587/cesa.2024.4201
BibTeX
@article{Almustafa2024,
author = {Almustafa, Abdulnaser J. A. and Kaya, Kemal and Mahmood, Ahmed A. J.},
title = {Design, synthesis and antimicrobial activities evaluation for new sulphathiazole amide compounds},
journal = {Chemical and Environmental Science Archives},
year = {2024},
doi = {10.47587/cesa.2024.4201}
}
EUVIMED